TY - JOUR
T1 - Documento di consenso intersocietario ANMCO/ISS/AMD/ANCE/ARCA/FADOI/ GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/ SID/SIF/SIMEU/SIMG/SIMI/SISA Colesterolo e rischio cardiovascolare: percorso diagnostico-terapeutico in Italia
AU - Ciaccio, Marcello
AU - Averna, Maurizio
AU - Ricciardi, Gualtiero
AU - Medea, Gerardo
AU - Parretti, Damiano
AU - Zito, Giovanni Battista
AU - Graziani, Maria Stella
AU - Ferrari, Roberto
AU - Ciaccio, Marcello
AU - Nardi, Federico
AU - Giampaoli, Simona
AU - Maseri, Attilio
AU - Colivicchi, Furio
AU - Filardi, Pasquale Perrone
AU - Gulizia, Michele Massimo
AU - Rossi, Francesco
AU - Maggioni, Aldo Pietro
AU - Musacchio, Nicoletta
AU - Gulizia, Michele Massimo
AU - Musacchio, Nicoletta
AU - Musacchio, Nicoletta
AU - Cricelli, Claudio
AU - Panno, Antonio Vittorio
AU - Scherillo, Marino
AU - Abrignani, Maurizio Giuseppe
AU - Musumeci, Giuseppe
AU - Ceriotti, Ferruccio
AU - Campanini, Mauro
AU - Di Lenarda, Andrea
AU - Bonora, Enzo
AU - Griffo, Raffaele
AU - Romeo, Francesco
AU - Averna, Maurizio
AU - Cantelli Forti, Giorgio
AU - Faggiano, Pompilio Massimo
AU - Perticone, Francesco
AU - Riccio, Carmine
AU - Catapano, Alberico
AU - Bolognese, Leonardo
AU - Mugelli, Alessandro
AU - Arca, Marcello
AU - Ruggieri, Maria Pia
AU - Rossi, Francesco
AU - Pusineri, Enrico
PY - 2016
Y1 - 2016
N2 - Atherosclerotic cardiovascular disease still represents the leading cause of death in western countries. A wealth of scientific evidence demonstrates that increased blood cholesterol levels have a major impact on the outbreak and progression of atherosclerotic plaques. Moreover, several cholesterol-lowering pharmacological agents, including statins and ezetimibe, have proven effective in improving clinical outcomes. This document is focused on the clinical management of hypercholesterolemia and has been conceived by 16 Italian medical associations with the support of the Italian National Institute of Health. The authors have considered with particular attention the role of hypercholesterolemia in the genesis of atherosclerotic cardiovascular disease. Besides, the implications of high cholesterol levels in the definition of the individual cardiovascular risk profile have been carefully analyzed, while all available therapeutic options for blood cholesterol reduction and cardiovascular risk mitigation have been considered. Finally, this document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolemia.
AB - Atherosclerotic cardiovascular disease still represents the leading cause of death in western countries. A wealth of scientific evidence demonstrates that increased blood cholesterol levels have a major impact on the outbreak and progression of atherosclerotic plaques. Moreover, several cholesterol-lowering pharmacological agents, including statins and ezetimibe, have proven effective in improving clinical outcomes. This document is focused on the clinical management of hypercholesterolemia and has been conceived by 16 Italian medical associations with the support of the Italian National Institute of Health. The authors have considered with particular attention the role of hypercholesterolemia in the genesis of atherosclerotic cardiovascular disease. Besides, the implications of high cholesterol levels in the definition of the individual cardiovascular risk profile have been carefully analyzed, while all available therapeutic options for blood cholesterol reduction and cardiovascular risk mitigation have been considered. Finally, this document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolemia.
UR - http://hdl.handle.net/10447/352043
UR - http://www.giornaledicardiologia.it/articoli.php?archivio=yes&vol_id=2264&id=24358
M3 - Article
VL - 17
SP - 3
EP - 57
JO - Giornale Italiano di Cardiologia
JF - Giornale Italiano di Cardiologia
SN - 1827-6806
ER -